Second Regular Session of the 122nd General Assembly (2022)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2021 Regular Session of the General Assembly.
HOUSE ENROLLED ACT No. 1254
AN ACT to amend the Indiana Code concerning health.
Be it enacted by the General Assembly of the State of Indiana:
SECTION 1. IC 16-41-17-2, AS AMENDED BY P.L.19-2020,
SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 2. (a) Subject to subsection (d), every infant shall
be given examinations at the earliest feasible time for the detection of
the following disorders:
(1) Phenylketonuria.
(2) Hypothyroidism.
(3) Hemoglobinopathies, including sickle cell anemia.
(4) Galactosemia.
(5) Maple Syrup urine disease.
(6) Homocystinuria.
(7) Inborn errors of metabolism that result in an intellectual
disability and that are designated by the state department.
(8) Congenital adrenal hyperplasia.
(9) Biotinidase deficiency.
(10) Disorders detected by tandem mass spectrometry or other
technologies with the same or greater detection capabilities as
tandem mass spectrometry, if the state department determines that
the technology is available for use by a designated laboratory
under section 7 of this chapter.
(11) Spinal muscular atrophy.
(12) Severe combined immunodeficiency.
HEA 1254 2
(13) Beginning July 1, 2020, Krabbe disease.
(14) Beginning July 1, 2020, Pompe disease.
(15) Beginning July 1, 2020, Hurler syndrome (MPS1).
(16) Adrenoleukodystrophy (ALD).
(17) Beginning July 1, 2022, and in addition to the disorders
listed in subdivisions (1) through (16), only a disorder
recommended by a perinatal genetics and genomics advisory
committee with expertise in newborn screening and through
protocols prescribed by the state department.
Beginning July 1, 2022, a perinatal genetics and genomics advisory
committee with expertise in newborn screening, and through
protocols established by the state department, may recommend the
addition of a disorder to, or deletion of a disorder from, the
required examination under this subsection. The state department
shall adopt rules under IC 4-22-2 to add disorders to, or delete
disorders from, the required examination under this subsection.
The state department shall include any disorder added to or
deleted from the required examination on a list on the state
department's Internet web site. The perinatal genetics and
genomics advisory committee shall affirm the addition of, or
deletion of, any disorder to the examination requirement on an
annual basis.
(b) Subject to subsection (d), every infant shall be given a
physiologic hearing screening examination at the earliest feasible time
for the detection of hearing impairments.
(c) Subject to subsection (d), every infant shall be given a pulse
oximetry screening examination in accordance with rules adopted by
the state department for the detection of low oxygen levels. Section
10(a)(2) of this chapter does not apply to this subsection.
(d) If a parent of an infant objects in writing, for reasons pertaining
to religious beliefs only, the infant is exempt from the examinations
required by this chapter.
HEA 1254 Speaker of the House of Representatives
President of the Senate
President Pro Tempore
Governor of the State of Indiana
Date: Time:
HEA 1254